Rumors of mega-consolidations in the Pharmaceutical sector have cropped up during the past month. A number of forces may be cited behind this speculation. One of the more timely reasons for consolidation, actual or proposed, is the need to spread the high costs of...
Biotech And Pharma Outspend All Other Sectors Email this article to a friend Email Editor Rarely have we seen a month in the health care merger and acquisition market where the financial results were as lopsided as May’s. Based on figures currently available, the...
Fifteen Deals Worth $7.8 Billion Announced in October Email Editor The month of October recorded a combined total of 15 mergers and acquisitions in the Biotechnology sector. This represents one-third of the 45 health care technology deals reported during the month,...
Twenty-Three Transactions Announced In June We have long characterized the Medical Device sector as one of the great stalwarts of the health care M&A market, one which could always be counted on to produce a steady and robust stream of deals. As with much else...
Deal Volume Rises 12% Over First Quarter Based on results now available, the merger and acquisition market in the health care industry generated 228 deals during the second quarter of 2009. This figure represents a 12% increase over the 203 deals recorded in the first...
FOR IMMEDIATE RELEASE Eleanor B. Meredith, Publisher 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com Norwalk, CT – June 10, 2009 — The Specialized Information Publishers Foundation (SIPF) awarded First Place to The Health Care...